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Abstract
Mutations in the gene for growth hormone releasing hormone receptor (GHRHR) cause isolated growth hormone deficiency
(IGHD) but this gene has not been found to affect normal variation in height. We performed a whole genome linkage analysis
for height in a population from northern Sweden and identified a regionon chromosome 7 with a lod-score of 4.7. TheGHRHR
gene is located in this region and typing of tagSNPs identified a haplotype that is associated with height (p=0.00077) in the
original study population. Analysis of a sample from an independent population from the most northern part of Sweden also
showed an association with height (p=0.0039) but with another haplotype in the GHRHR gene. Both haplotypes span the 39
part of the GHRHR gene, including the region in which most of the mutations in IGHD have been located. The effect size of
thesehaplotypesarelarger thanthatof any genepreviously associated with height, whichindicatesthatGHRHR mightbeone
of the most important genes so far identified affecting normal variation in human height.
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Introduction
Height is one of the most heritable traits in humans and since it
is easy to measure has become one of the most studied phenotypes.
Many genomic regions have been linked to the variation in stature,
but few of these regions have been replicated [1]. SNPs in a
number of genomic regions have recently been associated with
human stature, but similar to the linkage analysis, few findings
have been replicated between studies [2–4]. Although these
associations have highly significant p-values, the effect size of each
SNP is small and most of the loci contributing to variation in
height still remain unidentified.
One approach to increase the power in linkage and association
studies is to study small populations with increased linkage
disequilibrium and decreased genetic diversity. In a population
that has undergone a population bottleneck (or the founding of the
population from a small number of individuals followed by rapid
population growth) some alleles that were rare in the founding
population have been maintained or even increased their
frequency. One example is the Finnish population [5] were
numerous rare diseases have been characterized, and for most of
them a single gene and founding mutation has been identified [6].
Populations with this type of demographic history have been useful
for identifying rare recessive alleles, but common variants with
small effects have still been difficult to find. In an expanding
population LD decays with time, while in a continuously small
population LD is generated by genetic drift rather than founder
effect. Small populations with a historic constant size may
therefore be particularly suitable for identification of common
disease alleles [7]. However, few human populations have had a
demographic history that makes them candidates for such an
analysis. One such population is the Sami population of the
northern part of Scandinavia and Kola peninsula [8]. The Sami at
present have an estimated population size of less than 100 000
individuals [9] and are believed to have populated the area soon
after the last Glaciation, about 10 000 YBP. The LD in the Sami is
increased relative to other many other populations [8,10].
We have performed microsatellite marker based whole genome
linkage analysis using a familial material from the southern Swedish
Sami population. Linkage analysis was followed by typing of
tagSNPs in the growth hormone releasing hormone receptor gene
(GHRHR) located in the best linkage peak, both in the original
population and in an independent northern Swedish population. A
number of mutations in the GHRHR gene have previously been
associated with isolated growth hormone deficiency (IGHD) leading
to short stature, but no evidence has been found that GHRHR has
an effect on normal variation in human stature.
Results
Linkage analysis of microsatellite markers
The heritability for height in the VB cohort was estimated to
0.90 (p=7.0E -23 Std. Error: 0.069), which is somewhat higher
than in most populations [11]. In the genome-wide linkage
analysis using 337 autosomal markers, two regions showed at least
suggestive linkage to height (chromosome 7, lod=2.42; and
chromosome 9, lod=3.58) (Figure 1). The peak on chromosome 7
was wide and many markers contributed to the linkage signal.
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4464Analysis of these and an additional 29 microsatellite markers
(Supplementary material: Table S1) within 145 cM on chromo-
some 7 resulted in a highly significant lod score of 4.67 (Figure 1).
The initial peak on chromosome 9 was due to three markers
(d9s302, d9s930 and d9s938) and analysis of these and 12
additional markers within a 25 cM region reduced the lod from
3.58 to 1.33 (Figure 1).
SNP association and haplotype scoring
We searched for candidate genes within the peak on
chromosome 7 (Figure 1), starting at 11 cM and ending at
70 cM. This region contains as many as 394 genes. However we
focused on the GHRHR gene which is of special interest since
mutations in this gene cause isolated growth hormone deficiency
(IGHD) [12–15]. In order to cover most of the genetic variation in
the GHRHR gene, 9 tagSNPs within the gene and in the flanking
regions were typed. Of the 9 SNPs, 4 were associated with
variation in height (Table 1). Including all 9 markers, we identified
one haplotype that was negatively associated with height, and that
span the entire GHRHR gene region. This haplotype (character-
ized by the combination rs17159772-C, rs4988494-T, rs2267721-
G, rs4988498-G, rs740336-C, rs2074780-G, rs4988504-G,
rs4988505-G, rs2228078-T) had a frequency of 6.6% and could
be perfectly tagged by 5 of the SNPs (rs17159772-C, rs4988494-T,
rs2267721-G, rs4988498-G, rs4988505-G) (Table 2).
Replication attempt in an independent population
We used a population sample from the County of Norrbotten
(NB), northern Sweden, which is part of the Northern Swedish
Population Health Study, for an independent test of the
association of the GHRHR haplotype with height. In total 10
SNPs were typed in NB, of which one (rs4988498) replicated the
single SNP associations found in VB. However this SNP has a very
low frequecy in NB and consequently the result could represent a
false positive, even thought the effect is in the same direction in
both cohorts. The 5 SNPs that tagged the haplotype negatively
associated with height in VB also tagged a haplotype negatively
associated with height in NB (Table 2). The two associated
haplotypes in the VB and NB cohorts were found at similar
frequency (6.6% vs. 8.7%) and were identical for the last three
SNPs (rs2267721, rs4988498 and rs4988505).
The LD pattern in the GHRHR gene region in the HapMap
CEU population clearly shows two blocks with high LD, separated
by a region with low LD (Figure 2). The first block contains the first
exon and most of the first intron, whereas the second LD block
contains the remainder of the GHRHR gene. The two haplotypes
associated with height in the VB and NB cohorts were identical for
the two SNPs in the second LD block (rs4988498 and rs4988505)
and for one SNP (rs2267721) located in between the blocks, but not
for the SNPs within the first LD block (rs2302019 and rs2267723).
This suggests that the SNPs affecting stature in the two cohorts are
located downstream of the first intron of the GHRHR gene.
Figure 1. QTLs for height in the VB population. A) Multipoint LOD scores across the genome from the initial microsatellite scan. B) Multipoint
LOD scores in the chromosome 7 and C) in the chromosome 9 region both including additional markers for fine-mapping. The location of the GHRHR
gene is indicated by ‘‘X’’ in figure B.
doi:10.1371/journal.pone.0004464.g001
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were p=7.6610
24 and p=3.9610
23 in the VB and NB cohorts,
respectively. For the VB cohort we also found one 5-marker
haplotype that was positively associated with stature, but the
frequency was low (2.4%) and no haplotype was positively
associated in the NB cohort (Table 2).
Haplotype diversity in a worldwide perspective
The haplotype diversity of the GHRHR gene region has
previously been studied using the genome diversity panel,
including 1,000 individuals from 52 populations, by analysis of
54 SNPs within a 53.4 kb region from about 28 kb upstream to
9 kb downstream of the gene (Supplementary material: Table S2).
In the VB cohort the 5-marker haplotype that was negatively
associated with height (Table 2) can be expanded to a 7-marker
haplotype (rs17159772, rs4988494, rs2267721, rs4988498,
rs740336, rs4988505 and rs2228078) where all SNPs overlapped
with those typed in the diversity panel. The 7-marker haplotype
negatively associated with height was found at a frequency of 6.6%
in the VB cohort, and had a frequencies of at least 1% in the
European diversity panel (Haplo_365). Similarly, the 5-marker
haplotype negatively associated with height in the NB cohort
(Table 2) can be expanded to a 10-marker haplotype (rs10278927,
rs4723034, rs17159772, rs2302019, rs4988494, rs2267721,
rs2267723, rs4988498, rs2741, rs4988505) that was present at a
frequency of 4.8%. This haplotype matched two of the diversity
panel haplotypes (denoted Haplo_28 and Haplo_388) occurring at
frequencies of 4.4% and 1.9%, respectively, in the European
populations.
The three haplotypes in the gene diversity panel (Haplo_365, 28
and 388) that matched the negatively associated haplotypes in the
VB and NB cohorts were identical from markers rs4988494 to
rs11760522, a region of more than 20 kb that includes 29 SNPs
Table 1. TagSNPs in the GHRHR gene region and the
estimated association to variation height in the VB and NB
cohort.
Cohort SNP name Position N MAF Beta* P-value
NB rs10265249 30952101 649 0.023 0.233 0.838
NB rs4723034 30961436 651 0.242 0.235 0.437
VB rs17159772 30969438 507 0.260 0.573 0.142
NB rs17159772 30969438 696 0.242 20.111 0.719
NB rs2302019 30969948 651 0.306 0.177 0.514
VB rs4988494 30970344 458 0.109 21.160 0.093
NB rs4988494 30970344 693 0.064 0.690 0.331
VB rs2267721 30971968 497 0.328 20.162 0.637
NB rs2267721 30971968 695 0.257 20.031 0.917
NB rs2267723 30973467 651 0.487 0.334 0.057
VB rs4988498 30976101 183 0.036 4.536 0.031
NB rs4988498 30976101 651 0.004 6.727 0.023
VB rs740336 30978202 506 0.020 0.123 0.938
VB rs2074780 30980382 508 0.025 3.461 0.015
NB rs2741 30982090 651 0.214 0.496 0.132
VB rs4988504 30982543 506 0.065 0.829 0.317
VB rs4988505 30983628 501 0.296 20.372 0.011
NB rs4988505 30983628 651 0.266 0.159 0.574
VB rs2228078 30985377 506 0.026 22.745 0.048
*Beta is the effect in cm for the minor allele.
doi:10.1371/journal.pone.0004464.t001
Table 2. Association of the 5-marker haplotypes and height in the VB and NB cohort.
VB
rs17159772 rs4988494 rs2267721 rs4988498 rs4988505 Frequency Hap-Score* p-value
VB_hap#1 C T G G G 0.07 23.36 0.00077
VB_hap#2 C CCGG0 . 5 0 21.43 0.15278
VB_hap#3 C T C G G 0.03 0.59 0.55240
VB_hap#4 T C G G C 0.14 0.82 0.41177
VB_hap#5 T C G G G 0.11 0.90 0.36837
VB_hap#6 C T C G C 0.02 1.32 0.18661
VB_hap#7 T C G T C 0.01 1.41 0.16001
VB_hap#8 C C C G C 0.10 1.88 0.06036
VB_hap#9 C C C T C 0.02 2.31 0.02088
NB
rs17159772 rs4988494 rs2267721 rs4988498 rs4988505 Frequency Hap-Score* p-value
NB_hap#1 T C G G G 0.09 22.89 0.00391
NB_hap#2 C CCGG0 . 5 9 20.08 0.93779
NB_hap#3 C T G G G 0.01 0.03 0.97610
NB_hap#4 C C C G C 0.10 0.62 0.53658
NB_hap#5 T C G G C 0.16 0.78 0.43774
NB_hap#6 C T C G G 0.04 1.04 0.30049
*The haplotype-score is a relative measure of increase/decrease in average height for individuals carrying the haplotype.
doi:10.1371/journal.pone.0004464.t002
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intron and downstream. A total of 12.7% of individuals of
European descent in the gene diversity panel carry this extended
haplotype.
We also identified one haplotype in the VB cohort that was
positively associated with stature (p=6.1610
23) (Table 2). This
haplotype matched Haplo_325 with a frequency of 3.2% in the
gene diversity panel, which is similar to the frequency in VB
(2.4%). As mentioned above the VB and NB haplotypes negatively
associated with stature are identical for an extended haplotype. In
contrast, European Haplo_325 in the diversity panel, which
matched the VB haplotype positively associated with stature,
differs at 11 out of the 29 positions.
Haplotype effect
We inferred haplotypes for each individual based on the 5-
marker haplotypes (rs17159772, rs4988494, rs2267721, rs4988498
and rs4988505) and compared the height of individuals that are
likely (probability.0.5) to carry the negatively associated haplo-
type to that of non-carriers (Figure 3). In the VB cohort the height
of individuals carrying the associated haplotypes were 3.8 cm and
2.5 cm shorter for males and females, respectively, and in the NB
cohort 2.1 cm and 1.2 cm shorter for males and females,
respectively. After correcting for sex, age and population affinity,
carrying or not carrying the negatively associated haplotype
accounts for as much as 1.8% of the variation in height in our two
populations (0.9% without adjustment).
Discussion
We have identified a region on chromosome 7 linked to height in a
family based study from northern Sweden. This chromosomal region
has been proposed to be linked to height earlier [16], supporting our
findings. The linkage region is large (about 60 cM) and gene-dense
but includes one obvious candidate, the GHRHR gene, involved in
growth hormone(GH) regulation.Sincethere are a totalof 394 genes
in the region, we cannot exclude that the linkage signal is due to
variants in another gene. However, our analysis revealed an
association between height and single markers as well as haplotypes
in the GHRHR gene in the original Swedish population, as well an
independent population sample. The two haplotypes negatively
associated with height in the two Swedish populations are identical
forthreeSNPslocatedinthefirstintronoftheGHRHRgeneandthe
downstreamregion.The39part of our two haplotypes, spanning from
Figure 2. LD plot of the GHRHR gene region. Heat-map of the LD (r
2) in the HapMap CEU population. The pairwise LD between SNPs and the
location of the GHRHR gene.
doi:10.1371/journal.pone.0004464.g002
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common haplotype that occurs at a frequency of 12.7% in European
populations [17,18].
Growth hormone (GH) is primarily involved in stimulating
skeletal and visceral growth, but also has an important function in
protein, lipid and carbohydrate metabolism. The synthesis and
secretion of GH is mainly dependent on three hormones, GH-
releasing hormone (GHRH), GH secretagogue (GHS) and
somatostatin (SS). GHRH stimulates, via the GHRH receptor
(GHRHR), GH synthesis and secretion. Isolated growth hormone
deficiency (IGHD) has been clinically divided into three categories
(types 1–3), although this subdivision does not take into account
the molecular heterogeneity within each type. Patients with IGHD
have presented with muations in either the GH, GHRHR or GH1
genes. A number of different mutations have been identified in the
GHRHR gene leading to IGHD [12–15]. Mutations have been
found in the promoter leading to reduced promoter activity [15]
and the splice site of the first intron [13], resulting in changes of
the concentration of components of the IGF (insulin-like growth
factor) axis [19]. Five non-synonymous mutations have also been
identified in familiar IGHD, at least one of which has been shown
to result in loss of functionality of the GHRH receptor [12–15]. All
5 non-synonymous mutations are located within the boundaries of
the extended haplotype region we found to be negatively
associated with normal variation in height. Single SNPs and
haplotypes in the GHRHR gene region have also been reported to
be associated with normal short (not dwarfism) or tall stature, but
these findings were not replicated in either of two independent
population samples [20]. The haplotypes and all but one of the
SNPs associated with height in the study by Lettre et al [20] are
located upstream or in the promoter region of the GHRHR gene.
The last SNP is located downstream of the gene, but their data
does not include an analysis of haplotypes spanning the part of the
GHRHR gene we found to be associated with height.
Linkage analysis is most suitable to detect rare variants with
strong effects whereas association is most powerful to detect
common variants with lower effects. TagSNPs chosen from the
HapMap data are also optimized for detection of common
variants [10]. To increase the power of tagSNPs to detect rare
variants, more dynamic haplotype-based tagging methods can be
used rather than single marker tests [21]. This agrees with our
results showing that the single markers did not replicate the
association of the GHRHR gene and normal variation in height
and that the lowest p-values in the initial association analyses
(p=0.011) were not low enough to be remain significant after
Bonferroni-correction for the 9 SNPs tested. Rather, analyses of 5-
marker haplotypes was needed to detect a strong association with
height. The similarity in frequency of the 5-marker haplotypes
associated with height in the VB and NB cohorts, and the identity
of the haplotype over a region of more than 20 kb, including 29
SNPs, suggests that if there is a causative variant that is shared
between populations, it is relatively infrequent (,10%) and located
downstream of the first intron.
The estimated effect size of the GHRHR haplotypes is
considerably higher than that of other SNPs found to be associated
with height [2–4,22,23]. For instance, the SNP in the HMGA2
gene region is estimated to explain 0.3% of the variation in height,
and the average increase per risk allele is 0.4 cm. Our associated
haplotype accounts for 1.8% of the variation in height after
adjusting for sex, age and population affinity, and a decrease in
height with as much as 1.2–3.8 cm, depending on sex and
population cohort. The large effect size and the association of
haplotypes in two independent populations, makes the GHRHR
haplotype the strongest genetic contributor to normal variation
human in height so far identified.
Materials and Methods
Samples
Samples for the linkage analysis (n=436) were obtained from
the southern Swedish Sami, County of Va ¨sterbotten (denoted the
VB cohort). The individuals belong to 137 families. Association
analysis was performed in the VB cohort and included 510
individuals, corresponding to the 436 individuals from the linkage
analysis and an additional 74 individuals with no relatives present
in the study. To replicate the association results, 699 samples were
obtained from northern Sweden, County of Norrbotten (NB
cohort) included in the Northern Swedish Population Health
Study. A general description of the families, height, sex and age of
the two populations can be found in Supplementary material:
Table S3.
Ethics Statement
This study was approved by the regional ethics committee.
Marker selection
337 autosomal microsatellite markers (based on the Weber
screening set 6: (http://research.marshfieldclinic.org/genetics/
sets/Set6ScreenFrames.htm) were analyzed for the VB cohort.
For fine mapping of two chromosomal regions, 29 additional
markers on chromosome 7 and 12 markers on chromosome 9
(Supplementary material: Table S1) were selected from the NCBI
(http://www.ncbi.nlm.nih.gov) and the ENSEMBL (http://www.
Figure 3. Effect of the haplotype on height. Average and standard
error in height for individuals not carrying the haplotype associated
with short stature (a) and individuals carrying the haplotype associated
with short stature (b). The number of individuals in the group (a:b) are
in VB females 37:230, VB males: 36:218, NB females: 33:338, NB males
30:299.
doi:10.1371/journal.pone.0004464.g003
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from the CEU panel (Americans of European ancestry) of the
phase II HapMap Project [24]. The SNPs were chosen to spatially
cover and to capture most of the genetic variation at the candidate
gene. For the SNP selection we used the pairwise tagging
approach implemented in the Tagger software [21], including all
SNPs with a frequency of more than 1% and using a threshold of
0.8 as the cut-off for two SNPs being tagged by each other. The 9
SNPs chosen (rs17159772, rs4988494, rs2267721, rs4988498,
rs740336, rs2074780, rs4988504, rs4988505 and rs2228078) were
estimated to capture 86% of all common variants (r
2.0.8) within
the GHRHR gene. For the replication, 5 SNPs tagging the
haplotype in the VB cohort with the strongest association were
chosen and an additional 5 SNPs (rs10265249, rs4723034,
rs2302019, rs2267723 and rs2741) to further distinguish between
different haplotypes in the diversity panel (Supplementary
material: Table S2).
Genotyping
Microsatellite markers. All markers were amplified using
the same standard PCR protocol. For each 5 ml reaction, 10 ng
DNA was used. The PCR contained 2.25 mM MgCl2, 200 mMo f
each dNTP, 0.2 mM of each primer and 0.125 u HotStarTaq DNA
Polymerase. The thermocycle parameters used were: an initial
15 min denaturation at 95uC followed by 30 sec at 95uC, 30 sec at
55uC and 60 sec at 72uC for 35 cycles. For some markers from the
additional two regions a 60-55uC touch down thermocycle program
was used. All PCRs were performed using the ABI Prism
TM 877
integrated thermal cycler. The forward primer of each marker was
labeled with one of the following fluorescent dyes: HEX, NED or
FAM. The labeled fragments were separated on an ABI Prism
TM
3700 DNA Analyzer instrument. Genotype calling was performed
using the AC genotyping software [25], the ABI GenoTyper
TM or
GeneMapper
TM genotyping software.
SNP markers. SNPs were genotyped using TaqMan
genotyping assays (Applied Biosystems) employing Applied
Biosystems (AB) designed reagents mixes and oligonucleotide/
primer pools, and the 7900 HT Fast Real Time PCR system
(Applied Biosystems) according to the manufacturer’s instructions.
Statistic analysis
During quality control, all markers were checked for mendelian
errors using the PedCheck software (http://watson.hgen.pitt.edu/
register/docs/pedcheck.html) and markers that were not in
Hardy-Weinberg equilibrium (p,0.05) were removed from
further analyses. In all analyses, height trait was corrected for
sex and age and transformed to be normally distributed with a
mean of zero and standard deviation of one. Heritability was
estimated using SOLAR software [26]
Linkage analysis. Linkage analysis was performed using
SOLAR software [26]. Multipoint identical by descent matrixes
were calculated every 1 cM along the chromosomes. Multipoint
lod-scores were calculated in the first step every 10 cM throughout
the genome and in the second step every 1 cM within all region
with a lod-score above 0.56.
Association and haplotype scoring. Association analysis
was performed using the GenABEL software [27]. For single
markers, a score test was used for association between a trait and
genetic polymorphism in samples of related individuals [28] based
on the kinship matrix calculated based on the pedigree
information. For haplotypes, maximum likelihood estimates of
the haplotype frequencies and the posterior probabilities of the
pairs of haplotypes for each subject were calculated using an EM
algorithm implemented in the R-package haplo.stats version 1.3.1,
followed by a score test for the association of haplotypes with the
traits [29]. The fraction of the variance in height explained by the
haplotypes were estimated by analysis of variance using a
generalized linear model including sex, age, population affinity
(VB or NB) and haplotype status (carrying or not carrying the
negatively associated allele).
Haplotypediversityina worldwideperspective. Haplotype
frequencies for the Human Genome Diversity Panel [17,18] were
downloaded from the Fondation Jean Dausset - CEPH World Wide
Web server (http://www.cephb.fr/) using the HGDP - CEPH Project
- Genotype Database V2.0. The Human Genome Diversity Panel
represents 52 populations with range of different histories.
Supporting Information
Table S1 Microsatellite markers typed in the fine-mapping.
Found at: doi:10.1371/journal.pone.0004464.s001 (0.05 MB
DOC)
Table S2 The genotype and SNP infomration for the diversity
panel can be found at the Fondation Jean Dausset - CEPH World
Wide Web server (http://www.cephb.fr/). SNPs are colored as:
Yellow: The overlap between VB, NB and diversity panel.
Turquoise: The ovelap between VB and diversity panel. Pink:
The overlap between NB and diversity panel. The haplotypes are
colored as: Pink: The NB haplotype negatively associated with
stature. Turquoise: The VB haplotype negatively associated with
stature. Lilac: The VB haplotype positively associated with stature.
Green: The most common haplotype both in NB (27%)and the
Eurpean diversitypanel populations.
Found at: doi:10.1371/journal.pone.0004464.s002 (0.16 MB
PDF)
Table S3 General description of the two population cohorts
Found at: doi:10.1371/journal.pone.0004464.s003 (0.05 MB
DOC)
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